This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04061/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04061/identifier/drugbank/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04061/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04061/identifier/pubchem-compound/

Statements

Subject Item
n2:DB04061
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB04061 n11:DB04061
dcterms:title
Alpha-Amino-2-Indanacetic Acid
adms:identifier
n8:DB04061 n9:46508579 n10:IGL n12:11310031
n3:IUPAC-Name
n4:271B5D61-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5D67-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5D66-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5D63-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5D64-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5D65-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5D5F-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5D60-363D-11E5-9242-09173F13E4C5 n4:271B5D5D-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5D5E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5D6D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5D6E-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5D68-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5D69-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5D6B-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5D6A-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5D6C-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5D73-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5D75-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5D76-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5D72-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5D71-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5D74-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5D62-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5D6F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5D70-363D-11E5-9242-09173F13E4C5